DIURETICS

Orbit’sDIURETICS

Portfolio

A diuretic is any substance that promotes diuresis, the increased production of urine. This includes forced diuresis. There are several categories of diuretics. All diuretics increase the excretion of water from bodies, although each class does so in a distinct way. Alternatively, an antidiuretic such as vasopressin (antidiuretic hormone), is an agent or drug which reduces the excretion of water in urine.

Below listed the Orbit’s Portfolio

NAME

Furosemide Injection BP 10 mg/ml

Furosemide Tablets BP 50 mg

Furosemide Tablets BP 40 mg

Acetazolamide Tablets BP 250 mg

Alfuzosin HCL 5mg

Alfuzosin HCL 5mg + Dutastried 0.5mg

Dutastride 0.5mg

Prazosin Hcl SR 2.5/5/10 mg

Tamsulosin Hcl 0.4mg + Dutastriede 0.5mg

Tamsulosin Hydrochloride (ER) 0.4mg + Finastriede 5mg

Temsulosin 0.4mg

Spirolactone 25mg + Frusemide 40mg

Torsemide 5mg / 10mg / 20mg / 40mg / 100mg

Torsemide 10mg + Spirnolactone 25mg

Sodium Bi Carbonate 500mg / 1g

DIURETICS

ABOUT ORBIT

Orbit LifeSciences - Pioneer In Delivering Health Outcomes

The information in this document is the property of Orbit or its licensors and is protected by copyright and other intellectual property laws. The information in this document is confidential and may be legally privileged or exempt from disclosure under applicable law and shall not attach any liability on the originator. It is intended solely for the addressee. This document shall and will neither be copied, distributed nor have the contents disseminated to anyone else aside from the addressee, without the prior approval of Alhev Access to this document by anyone else is unauthorized. If you are not the intended recipient, or a person responsible for delivery of this document to an intended recipient, any disclosure, copying, distribution or any action taken or omitted to be taken in reliance on it, is prohibited and may be unlawful. Also, you may not copy, print, store, deliver, disseminate or distribute this document to anyone. If you have received this document in error or in such a case, as described herein, please destroy this document and any copies immediately and notify the sender by email at info@orbit.com

When addressed to our clients, any opinions or advice contained in this document are subject to the terms and conditions expressed in the governing Orbit - client engagement letter. While the Orbit team tries its best to keep the information up-to-date in line with the evolving trends, Orbit assumes no responsibility for the validity and correctness of the information provided.

Orbit Lifesciences is on a mission to deliver quality health through its innovative, evolving and growing product portfolio. Launched in 2004, Orbit is a part of Orbit Group.

With a strong focus on innovation, speed of execution & extensive networking Today, orbit Lifescience is reckoned as one of the fastest growing, multi-faceted progressive professional organization in building and delivering mutually beneficial business propositions ranging from In-licensing, Out-licensing and Exports of Finished Formulations.

This is Orbit Proprietary Material.